Today the Welltrinsic Sleep Network and Advanced Brain Monitoring Inc announced a new partnership to make the Night Shift sleep positioner available at discounted pricing for the network’s member physicians.
Night Shift offers an innovative, noninvasive solution for positional obstructive sleep apnea (OSA), a form of sleep-disordered breathing that occurs when sleeping in the supine position. Worn on the back of the neck, Night Shift delivers vibro-tactile feedback to limit supine sleep, slowly increasing the intensity of the vibration until the user changes positions.
The partnership with Advanced Brain Monitoring enables Welltrinsic members to provide Night Shift to patients at a discounted price. Currently, the Welltrinsic Sleep Network is offering free membership enrollment to board certified sleep medicine physicians.
“Night Shift is a state-of-the-art treatment that gives sleep physicians another therapeutic option when providing comprehensive care for patients with obstructive sleep apnea,” says Welltrinsic Sleep Network president and CEO Dr Lawrence Epstein, in a release. “This partnership is one more example of Welltrinsic’s commitment to equip sleep specialists with the tools necessary to provide high-quality, value-based care for patients with a sleep disorder.”
A study published last month in the Journal of Clinical Sleep Medicine confirmed the clinical effectiveness of Night Shift, showing that it significantly reduced sleep-disordered breathing and improved sleep quality across all OSA severity groups. The study of patients between the ages of 18 and 75 years also found that the median compliance rate was 96% during the 4-week treatment period.
Night Shift is also an intelligent, interactive monitor, measuring sleep quality and the frequency of unhealthy loud snoring. A feature of the device is the ability to monitor compliance with therapy through the wireless transmission of position data to a portal that is accessible to physicians.
“Night Shift is proven to be a safe, clinically effective, and comfortable treatment option for sleep apnea patients,” says Advanced Brain Monitoring chief medical officer Dr Philip Westbrook. “By providing the capability to monitor compliance and efficacy, Night Shift also offers the treating physician a wealth of data to help ensure optimal patient outcomes.”
According to the American Academy of Sleep Medicine (AASM), positional therapy is an effective secondary therapy or can be a supplement to primary therapies for OSA in select patients. It also can be a primary therapy when correction of OSA by position has been documented with polysomnography.
